CELLERANT THERAPEUTICS

cellerant-therapeutics-logo

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s Romyelocel-L is a universal cell therapy that does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. It was founded in 2003 and headquartered in San Carlos, California.

#SimilarOrganizations #People #Financial #Website #More

CELLERANT THERAPEUTICS

Social Links:

Industry:
Biotechnology Clinical Trials Therapeutics

Founded:
2003-01-01

Address:
San Carlos, California, United States

Country:
United States

Website Url:
http://www.cellerant.com

Total Employee:
101+

Status:
Active

Contact:
(650)232-2122

Email Addresses:
info@cellerant.com

Total Funding:
109.77 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Cloudflare Google Google Cloud OpenResty Gravity Forms Google Adsense


Similar Organizations

argen-x-logo

arGEN-X

arGEN-X offers a platform for antibody lead choice that supports the discovery of human antibody therapeutics.

cocrystal-pharma-logo

Cocrystal Pharma

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

not_available_image

Richard G.Rathmann Board Of Directors @ Cellerant Therapeutics
Board_member

gisela-s-schwab_image

Gisela S. Schwab Board Of Directors @ Cellerant Therapeutics
Board_member

steve-greenberg_image

Steve Greenberg Board Of Directors @ Cellerant Therapeutics
Board_member

not_available_image

Richard Chyette Board Of Directors @ Cellerant Therapeutics
Board_member

Current Employees Featured

not_available_image

Rob Tessler
Rob Tessler Vice President of Research & Development @ Cellerant Therapeutics
Vice President of Research & Development

irving-l-weissman_image

Irving L. Weissman
Irving L. Weissman Founder @ Cellerant Therapeutics
Founder

not_available_image

Jun S.Yoon
Jun S.Yoon Vice President, Corporate Development @ Cellerant Therapeutics
Vice President, Corporate Development

Founder


irving-l-weissman_image

Irving L. Weissman

Investors List

camelot-collectables_image

Camelot Collectables

Camelot Collectables investment in Venture Round - Cellerant Therapeutics

allen-and-company_image

Allen & Company

Allen & Company investment in Venture Round - Cellerant Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Cellerant Therapeutics

camelot-venture-group_image

Camelot Venture Group

Camelot Venture Group investment in Series B - Cellerant Therapeutics

cx-venture-group_image

CX Venture Group

CX Venture Group investment in Series B - Cellerant Therapeutics

allen-and-company_image

Allen & Company

Allen & Company investment in Series B - Cellerant Therapeutics

george-rathmann_image

George Rathmann

George Rathmann investment in Series B - Cellerant Therapeutics

novel-bioventures_image

Novel Bioventures

Novel Bioventures investment in Series B - Cellerant Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Cellerant Therapeutics

allen-and-company_image

Allen & Company

Allen & Company investment in Series A - Cellerant Therapeutics

Official Site Inspections

http://www.cellerant.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 13.248.169.48
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Cellerant Therapeutics"

Cellerant Therapeutics - LinkedIn

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s ...See details»

Cellerant Therapeutics Company Profile 2024: Valuation, Funding ...

Cellerant Therapeutics is headquartered in Newark, CA. What is the size of Cellerant Therapeutics? Cellerant Therapeutics has 4 total employees. What industry is Cellerant …See details»

Cellerant Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Cellerant Therapeutics, Inc. of Newark, CA. Get the latest business insights from Dun & Bradstreet.See details»

Cellerant Therapeutics, Inc. - Scientist.com

Cellerant’s lead product, CLT-008, is a myeloid progenitor cell therapy currently in Phase 2 clinical development in patients with acute myeloid leukemia (AML). The Company also has a Cancer …See details»

Cellerant Therapeutics, Inc - VentureRadar

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. ... We are proud to offer Contract Development and …See details»

Cellerant Therapeutics - Craft

Cellerant Therapeutics is a clinical-stage biotech company that develops cell- and antibody-based immunotherapies. It provides a cancer stem cell (CSC) antibody discovery program that …See details»

Cellerant Therapeutics Inc - Company Profile and News

Cellerant Therapeutics, Inc. was founded in 2000. The company's line of business includes providing commercial physical and biological research and development. ...See details»

Cellerant Therapeutics - Funding, Financials, Valuation & Investors

Cellerant Therapeutics is funded by 7 investors. Camelot Collectables and Allen & Company are the most recent investors. Cellerant Therapeutics has a post-money valuation in the range of …See details»

Cellerant Therapeutics - Products, Competitors, Financials, …

Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a Cancer Stem Cell (CSC) antibody …See details»

Cellerant Therapeutics - Contacts, Employees, Board Members, …

Organization. Cellerant Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of …See details»

Cellerant Therapeutics Inc. - BioCentury Company Profiles - BCIQ

Jan 22, 2021 Cellerant Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Retail Software and POS System | Celerant Technology

Celerant offers retail stores an a complete POS system for efficient retail management. Explore our retail solutions!See details»

Cellerant Therapeutics Announces Key Additions to Sr.

Feb 7, 2011 Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in patients undergoing cord blood transplantation. The Company is developing CLT-008 …See details»

Cellerant Therapeutics Awarded Additional $16.7 ... - Fierce Biotech

Sep 15, 2011 Cellerant’s lead product, CLT-008, is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a cancer stem cell (CSC) …See details»

Cellerant and DIA Join Forces to Drive Progress and ... - dialliance

Cellerant Consulting Group and Dental Innovation Alliance (DIA) are pleased to announce a strategic partnership that unites two of the most forward-thinking organizations in the dental …See details»

About Celerant | Innovating Retail Technology for Business Growth

Established in 1999, Celerant is a leading provider of cutting-edge retail software, catering to businesses ranging from startups to enterprises. Our comprehensive suite comprises cloud …See details»

Celerant - Crunchbase Company Profile & Funding

Celerant Technology, established in 1999, specializes in comprehensive retail software solutions for businesses of all sizes. Their platform offers a unified approach to retail management with …See details»

Cellerant Announces the 2021 Best of Class Technology Award …

Sep 2, 2021 Cellerant Consulting Group is pleased to announce the 2021 Cellerant Best of Class Technology Award winners. “During such a challenging year in dentistry, these …See details»

Cellerant announces the 2023 Best of Class Technology Award …

Nov 30, 2023 The 2023 Cellerant Best of Class Technology Award recipients are: 1. CS 9600 (Carestream Dental) 2. ChairsideCAD (Exocad) 3. MiniBio Auto-reader (Terragene) 4. Nova …See details»

linkstock.net © 2022. All rights reserved